- Home
- CMPS vs MVBF Comparison
CMPS vs MVBF Comparison
Compare CMPS & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- MVBF
- Stock Information
- Founded
- CMPS 2020
- MVBF 1997
- Country
- CMPS United Kingdom
- MVBF United States
- Employees
- CMPS N/A
- MVBF N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- MVBF Major Banks
- Sector
- CMPS Health Care
- MVBF Finance
- Exchange
- CMPS Nasdaq
- MVBF Nasdaq
- Market Cap
- CMPS 364.9M
- MVBF 278.3M
- IPO Year
- CMPS 2020
- MVBF N/A
- Fundamental
- Price
- CMPS $3.26
- MVBF $23.45
- Analyst Decision
- CMPS Strong Buy
- MVBF Buy
- Analyst Count
- CMPS 7
- MVBF 3
- Target Price
- CMPS $17.83
- MVBF $24.67
- AVG Volume (30 Days)
- CMPS 4.9M
- MVBF 49.5K
- Earning Date
- CMPS 07-31-2025
- MVBF 07-28-2025
- Dividend Yield
- CMPS N/A
- MVBF 2.93%
- EPS Growth
- CMPS N/A
- MVBF N/A
- EPS
- CMPS N/A
- MVBF 1.46
- Revenue
- CMPS N/A
- MVBF $146,101,000.00
- Revenue This Year
- CMPS N/A
- MVBF N/A
- Revenue Next Year
- CMPS N/A
- MVBF $14.22
- P/E Ratio
- CMPS N/A
- MVBF $16.07
- Revenue Growth
- CMPS N/A
- MVBF N/A
- 52 Week Low
- CMPS $2.25
- MVBF $15.59
- 52 Week High
- CMPS $8.54
- MVBF $25.24
- Technical
- Relative Strength Index (RSI)
- CMPS 43.65
- MVBF 84.28
- Support Level
- CMPS $2.25
- MVBF $20.26
- Resistance Level
- CMPS $3.50
- MVBF $23.51
- Average True Range (ATR)
- CMPS 0.37
- MVBF 0.56
- MACD
- CMPS -0.07
- MVBF 0.21
- Stochastic Oscillator
- CMPS 34.83
- MVBF 97.06
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.